Nevro gets FDA pre-market approval for spinal cord stimulation device
The Redwood City, California-based company previously got an FDA nod in May 2015 for the device, which delivers high-frequency electrical impulses of up to 10,000Hz to the spinal cord to avoid the tingling sensation known as paresthesia (HF10 therapy).